These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3390221

  • 1. Benzylacyclouridine. Pharmacokinetics, metabolism and biochemical effects in mice.
    Darnowski JW, Handschumacher RE.
    Biochem Pharmacol; 1988 Jul 01; 37(13):2613-8. PubMed ID: 3390221
    [Abstract] [Full Text] [Related]

  • 2. Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine.
    Darnowski JW, Handschumacher RE, Wiegand RA, Goulette FA, Calabresi P.
    Biochem Pharmacol; 1991 Jun 15; 41(12):2031-6. PubMed ID: 2039551
    [Abstract] [Full Text] [Related]

  • 3. Species-dependent differences in the biochemical effects and metabolism of 5-benzylacyclouridine.
    Davis ST, Joyner SS, Chandrasurin P, Baccanari DP.
    Biochem Pharmacol; 1993 Jan 07; 45(1):173-81. PubMed ID: 8424810
    [Abstract] [Full Text] [Related]

  • 4. Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.
    Sommadossi JP, Cretton EM, Kidd LB, McClure HM, Anderson DC, el Kouni MH.
    Cancer Chemother Pharmacol; 1995 Jan 07; 37(1-2):14-22. PubMed ID: 7497584
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver.
    Monks A, Ayers O, Cysyk RL.
    Biochem Pharmacol; 1983 Jul 01; 32(13):2003-9. PubMed ID: 6870929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase: relevance to chemotherapy.
    Ashour OM, Al Safarjalani ON, Naguib FN, Goudgaon NM, Schinazi RF, el Kouni MH.
    Cancer Chemother Pharmacol; 2000 Jul 01; 45(5):351-61. PubMed ID: 10803917
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
    Lee KH, el Kouni MH, Chu HS, Cha S.
    Cancer Res; 1984 Sep 01; 44(9):3744-8. PubMed ID: 6744292
    [Abstract] [Full Text] [Related]

  • 11. Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
    Falcone A, Darnowski JW, Ruprecht RM, Chu SH, Brunetti I, Calabresi P.
    Blood; 1990 Dec 01; 76(11):2216-21. PubMed ID: 2257295
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.
    Liu M, Cao D, Russell R, Handschumacher RE, Pizzorno G.
    Cancer Res; 1998 Dec 01; 58(23):5418-24. PubMed ID: 9850074
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.
    Peters GJ, van Groeningen CJ, Laurensse EJ, Lankelma J, Leyva A, Pinedo HM.
    Cancer Chemother Pharmacol; 1987 Dec 01; 20(2):101-8. PubMed ID: 3664929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A, van Groeningen CJ, Kraal I, Gall H, Peters GJ, Lankelma J, Pinedo HM.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [Abstract] [Full Text] [Related]

  • 20. Benzylacyclouridine reverses azidothymidine-induced marrow suppression without impairment of anti-human immunodeficiency virus activity.
    Calabresi P, Falcone A, St Clair MH, Wiemann MC, Chu SH, Darnowski JW.
    Blood; 1990 Dec 01; 76(11):2210-5. PubMed ID: 2257294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.